Trial intelligence / Profile preview

Dexmedetomidine as Adjuvant in TAP Block for C-Section

NCT02472522Completed

Sponsor
Tata Main Hospital
Start
May 2015
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of dexmedetomidine in postoperative pain, sponsored by Tata Main Hospital. Primary endpoint: Time After the TAP Block When Rescue Analgesia Was First Sought at 24 hours. Started May 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02472522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02472522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call